Texas Oncology PA ( Site 8001) — Longview, Texas

Texas Oncology PA ( Site 8001) is a clinical research site located in Longview, Texas, United States 75601.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology PA ( Site 8001) has participated in 1 clinical trials.

Therapeutic areas: Head and Neck Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Longview

Browse all research sites in Texas · View every site in Longview

• DCOL Center for Clinical Research
• Texas Oncology-Longview Cancer Center
• Longview Cancer Center
• GSK Investigational Site
• DCOL Ctr for Clin Res
• Research Site
• Texas Oncology - Northeast
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Diagnostic Clinic of Longview
• Texas Oncology Longview
• CHRISTUS Good Shepherd Medical Center (Site 080-031), 700 E. Marshall Ave.

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology PA ( Site 8001)?

Texas Oncology PA ( Site 8001) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology PA ( Site 8001) conducted?

Texas Oncology PA ( Site 8001) has 1 clinical trials on record. Their work covers Head and Neck Neoplasms.

Is Texas Oncology PA ( Site 8001) accredited by Crixeo Clinical Trials?

Texas Oncology PA ( Site 8001) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology PA ( Site 8001)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.